KRISTINE DROZD: Open Payments
NPI 1689985715 · NEW HAVEN, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 4 payments from 3 companies in 2025. Trend: 2023 $181 · 2024 $202 · 2025 $1,793
Consulting: $1,605Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 1 | $1,155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $450 |
| Gilead Sciences, Inc. | 2 | $188 |
Products named: XIFAXAN.
Industry payments across CT — which companies pay providers there.
